Ellume is a digital diagnostics company that specializes in the development, manufacturing, and commercialization of innovative diagnostic products aimed at enhancing healthcare accessibility and efficiency. Their flagship product, the Ellume COVID-19 Home Test, is notable for its rapid results, providing accurate outcomes in just 15 minutes. This test utilizes advanced fluorescent detection technology, which is typically reserved for clinical laboratories, making it one of the most reliable at-home antigen tests available. Additionally, Ellume incorporates sample quality controls in its tests to ensure accuracy, further solidifying its commitment to high-performance diagnostics.

The company has recently expanded its operations by establishing a significant manufacturing facility in Frederick, Maryland, which has the capacity to produce approximately 15 million COVID-19 Home Tests per month. This facility not only supports the ongoing pandemic response but also aims to bolster local employment, creating hundreds of jobs. Ellume's focus extends beyond COVID-19, as it is actively engaged in developing solutions for other infectious diseases, including tuberculosis, in collaboration with global partners. Their commitment to innovation in digital diagnostics positions Ellume as a leader in the healthcare sector, dedicated to improving public health outcomes through accessible and reliable testing solutions.

Australia

Ellume is an Australian based Health Technology company that develops and manufactures connected real-time diagnostics for doctors and consumers.  We achieve this by combining next-generation quantum dot diagnostics with connected care technologies. Our products are distinguished by their simplicity of design, ease of use, rapid time to result and connectivity. To learn more about Ellume, visit our website at www.ellumehealth.com.

Ellume

Company Details